Your browser doesn't support javascript.
loading
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.
Liu, Hongyan; Sridhar, Vikas S; Montemayor, Daniel; Lovblom, Leif Erik; Lytvyn, Yuliya; Ye, Hongping; Kim, Jiwan; Ali, Mir Tariq; Scarr, Daniel; Lawler, Patrick R; Perkins, Bruce A; Sharma, Kumar; Cherney, David Z I.
Afiliação
  • Liu H; Toronto General Hospital Research Institute, UHN, Toronto, Ontario, Canada.
  • Sridhar VS; Department of Medicine, Division of Nephrology, UHN, Toronto, Ontario, Canada.
  • Montemayor D; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Lovblom LE; Toronto General Hospital Research Institute, UHN, Toronto, Ontario, Canada.
  • Lytvyn Y; Department of Medicine, Division of Nephrology, UHN, Toronto, Ontario, Canada.
  • Ye H; Department of Medicine, Division of Nephrology, University of Toronto, Toronto, Ontario, Canada.
  • Kim J; Banting and Best Diabetes Centre, Toronto, Ontario, Canada.
  • Ali MT; Center for Renal Precision Medicine, Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Scarr D; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Lawler PR; Toronto General Hospital Research Institute, UHN, Toronto, Ontario, Canada.
  • Perkins BA; Department of Medicine, Division of Nephrology, University of Toronto, Toronto, Ontario, Canada.
  • Sharma K; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Cherney DZI; Center for Renal Precision Medicine, Division of Nephrology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Diabetes Obes Metab ; 23(11): 2466-2475, 2021 11.
Article em En | MEDLINE | ID: mdl-34251085
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá